Jeffrey S. Aronin is an entrepreneur and businessperson who founded 11 companies, among them: Harmony Biosciences Holdings, Inc., OVATION Pharmaceuticals, Inc. and Paragon Biosciences LLC and who has been the head of 12 different companies. Presently, Mr. Aronin occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Chairman of Innovation Development Institute, Inc., Non-Executive Chairman for Harmony Biosciences Holdings, Inc. (which he founded in 2017), Chairman & Chief Executive Officer at Paragon Biosciences LLC (which he founded in 2010), Chairman at Paragon Health Capital LLC (which he founded in 2019) (a subsidiary of Paragon Biosciences LLC), Chairman & Chief Executive Officer of Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018), Executive Chairman at Evozyne Inc (which he founded) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Jeffrey S. Aronin is also on the board of 12 other companies.

He previously was Chairman & Chief Executive Officer of Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer for Enterprise Technologies, Inc., President & Chief Executive Officer for OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer for Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.